Deltex Medical is delighted to be once again joining the Association of British HealthTech Industries (ABHI) UK Pavilion at Arab Health 2024. The exhibition–the largest event of its kind in the Middle East–brings together the healthcare world to network, share experience and do business. Last year’s show made history by being the most visited edition with 135,880 professionals visits from 183 countries and 3,358 exhibitors.
This year’s Arab Health event marks the official international launch of Deltex Medical’s new TrueVue haemodynamic monitoring system.
Precise, proven and now portable, TrueVue retains oesophageal Doppler monitoring (ODM+) technology at its heart. With its unparalleled clinical pedigree, the power of ODM+ is now even easier to deliver and applicable in more clinical settings than ever.
Biggest Raft of Changes
From its new user-friendly touchscreen interface to its battery-powered portability, the new product represents the biggest raft of changes to Deltex’s core system. Indeed Deltex claims that this is now the easiest to learn, simplest to use haemodynamic imaging technology ever.
CEO Andy Mears says; “The clinical standard for beat-to-beat ultrasound imaging of blood flow (stroke volume and cardiac output) has taken a leap forward in terms of usability and application.”
Easiest to Learn, Simplest to Use, More Clinical Settings
Haemodynamic monitoring using Deltex’s Oesophageal Doppler Monitoring is proven to deliver improved surgical and critical care outcomes. The new system means these benefits are easier than ever to apply to more clinical settings.
Key changes to TrueVue include:
- Haemodynamic monitoring in all settings: Compact new system is now portable and battery powered, making TrueVue applicable in a much broader range of clinical situations.
- Signal acquisition: Completely redeveloped signal processing with enhanced noise reduction (Dopplink).
- Signal maintenance: New Probe Holder ensures probe remains in desired orientation.
- Full control of your data: HD Touchscreen with completely redesigned, intuitive user interface.
Deltex Medical’s experts will be on hand to demonstrate the potential of its technology-leading haemodynamic monitoring system on Stand No H2.H50U.
New TrueVue: Another milestone on the mission to eliminate complications caused by haemodynamic instability.